Mark A. Espeland
Impact in
-
- Menopause: Health Impacts and Treatments
- Geriatrics and Gerontology top 0.2%
Papers in
-
- Menopause: Health Impacts and Treatments 43
-
- Dementia and Cognitive Impairment Research 58
- Co-authors
- Stephen B. Kritchevsky (24 shared papers)Stephen R. Rapp (78 shared papers)Sally A. Shumaker (33 shared papers)Karen Johnson (35 shared papers)Nir Barzilai (5 shared papers)Susan M. Resnick (56 shared papers)JoAnn E. Manson (50 shared papers)William B. Applegate (11 shared papers)
- Journals
- Alzheimer s & Dementia (38 papers)The Journals of Gerontology Series A (37 papers)Journal of the American Geriatrics Society (20 papers)Obesity (18 papers)Diabetes Care (11 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark A. Espeland
467 papers receiving 22.5k citations
Mark A. Espeland's Hit Papers
Peers
Comparison fields: 5 of 196
- Endocrinology, Diabetes and Metabolism 4.4k
- Geriatrics and Gerontology 731
- Complementary and Manual Therapy 408
- Aging 316
- Behavioral Neuroscience 542
Countries citing papers authored by Mark A. Espeland
This map shows the geographic impact of Mark A. Espeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Espeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Espeland more than expected).
Fields of papers citing papers by Mark A. Espeland
This network shows the impact of papers produced by Mark A. Espeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Espeland. The network helps show where Mark A. Espeland may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Espeland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 480 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults Hit paper breakdown → | 2014 | 1024 |
| 2 | Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons Hit paper breakdown → | 1998 | 858 |
| 3 | Metformin as a Tool to Target Aging Hit paper breakdown → | 2016 | 746 |
| 4 | Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women Hit paper breakdown → | 2003 | 700 |
| 5 | Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Hit paper breakdown → | 1994 | 685 |
| 6 | Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women<SUBTITLE>Women's Health Initiative Memory Study</SUBTITLE> Hit paper breakdown → | 2004 | 615 |
| 7 | Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Hit paper breakdown → | 1990 | 469 |
| 8 | Evaluation of the Azoospermic Patient Hit paper breakdown → | 1989 | 454 |
| 9 | Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes Hit paper breakdown → | 2019 | 410 |
| 10 | 2009 | 373 | |
| 11 | Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality Hit paper breakdown → | 2017 | 352 |
| 12 | Physical Rehabilitation for Older Patients Hospitalized for Heart Failure Hit paper breakdown → | 2021 | 349 |
| 13 | Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models Hit paper breakdown → | 2017 | 327 |
| 14 | Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults Hit paper breakdown → | 2015 | 305 |
| 15 | 1998 | 243 | |
| 16 | 2006 | 241 | |
| 17 | 2018 | 220 | |
| 18 | 2011 | 213 | |
| 19 | 2001 | 210 | |
| 20 | 2015 | 207 |
About Mark A. Espeland
Mark A. Espeland is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 480 papers that have together received 23.3k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (58 papers), Menopause: Health Impacts and Treatments (43 papers), Cardiovascular Health and Disease Prevention (23 papers), Air Quality and Health Impacts (22 papers), Estrogen and related hormone effects (18 papers), Traumatic Brain Injury Research (18 papers), Cerebrovascular and Carotid Artery Diseases (18 papers) and Blood Pressure and Hypertension Studies (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Geriatrics and Gerontology (731 citations), Complementary and Manual Therapy (408 citations), Aging (316 citations) and Behavioral Neuroscience (542 citations). Mark A. Espeland has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Stephen B. Kritchevsky, Stephen R. Rapp, Sally A. Shumaker, Karen Johnson, Nir Barzilai, Susan M. Resnick, JoAnn E. Manson, William B. Applegate, Jill P. Crandall and Jonathan P. Jarow. Their work appears in journals such as Alzheimer s & Dementia, The Journals of Gerontology Series A, Journal of the American Geriatrics Society, Obesity and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.